Innocan Pharma (INNPF) Operating Margin (2024 - 2025)
Innocan Pharma (INNPF) posted Operating Margin of 31.84% for the quarter ended Dec 31, 2025, up 2.68 percentage points from 29.16% a year earlier and up 49.69 percentage points from the prior quarter.
Powered by 
Analysis
Innocan Pharma (INNPF) Operating Margin (2024 - 2025) Analysis & Trends
For the year ended Dec 31, 2025, Innocan Pharma's Operating Margin came in at 4.72%, up 0.48 percentage points from the prior year.
- In prior years, Innocan Pharma's Operating Margin was 4.24% in the year ended Dec 31, 2024 (-23.61 pp) and 27.85% in the year ended Dec 31, 2023.
- The figure for the quarter ended Dec 31, 2025 stands as the highest quarterly Operating Margin in data going back to the quarter ended Mar 31, 2024.
- On a year-over-year basis, Operating Margin increased in two of the last four quarters, with an average year-over-year change of +1.10 percentage points.
- According to Business Quant data, Operating Margin for the three prior quarters was -17.85% (quarter ended Sep 30, 2025), 5.65% (quarter ended Jun 30, 2025) and 6.27% (quarter ended Mar 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 32.98% |
| 10 | Innocan Pharma | 5.78 Mn | 1.73 Mn | 4.43 Mn | 31.84% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 31.84% |
| Sep 30, 2025 | -17.85% |
| Jun 30, 2025 | 5.65% |
| Mar 31, 2025 | 6.27% |
| Dec 31, 2024 | 29.16% |
| Sep 30, 2024 | 4.08% |
| Jun 30, 2024 | 6.15% |
| Mar 31, 2024 | -17.91% |
API Access
Innocan Pharma Operating Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-margin&ticker=INNPF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-margin", "ticker": "INNPF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-margin&ticker=INNPF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();